Brimble et al. (2003), have reported equivalent hematologic efficacy when comparing anemia management by a predetermined protocol with usual care in a group of prevalent patients on dialysis. Interestingly, they also reported reduced r-HuEPO dosing requirements in the protocolized arm independent of iron use, suggesting another potential source of cost savings.